This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rogers, P. D.
Right arrow Articles by McDaniel, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rogers, P. D.
Right arrow Articles by McDaniel, L. S.

 Previous Article  |  Next Article 

Infection and Immunity, April 2003, p. 2087-2094, Vol. 71, No. 4
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.4.2087-2094.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Pneumolysin-Dependent and -Independent Gene Expression Identified by cDNA Microarray Analysis of THP-1 Human Mononuclear Cells Stimulated by Streptococcus pneumoniae

P. David Rogers,1 Justin Thornton,2 Katherine S. Barker,1 D. Olga McDaniel,3 Gordon S. Sacks,4 Edwin Swiatlo,2,5 and Larry S. McDaniel2,3,5*

Departments of Clinical Pharmacy and Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, Tennessee,1 Departments of Microbiology,2 Surgery,3 Division of Infectious Diseases, Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi,5 Pharmacy Practice Division, University of Wisconsin, Madison, Wisconsin4

Received 12 August 2002/ Returned for modification 24 September 2002/ Accepted 18 December 2002


arrow
ABSTRACT
 
Pneumolysin is an important virulence factor of Streptococcus pneumoniae, interacting with the membranes of host cells to elicit a multitude of inflammatory responses. We used cDNA microarrays to identify genes which are responsive to S. pneumoniae in a pneumolysin-dependent and -independent fashion. The THP-1 human monocytic cell line was coincubated for 3 h with medium alone, with the virulent type 2 S. pneumoniae strain D39, or with the isogenic strain PLN, which does not express pneumolysin. RNA was isolated from the monocytes and hybridized on cDNA microarrays. Of 4,133 genes evaluated, 142 were found to be responsive in a pneumolysin-dependent fashion, whereas 40 were found to be responsive independent of pneumolysin. Genes that were up-regulated in cells exposed to D39 relative to those exposed to PLN included genes encoding proteins such as mannose binding lectin 1, lysozyme, {alpha}-1 catenin, cadherin 17, caspases 4 and 6, macrophage inflammatory protein 1ß (MIP-1ß), interleukin 8 (IL-8), monocyte chemotactic protein 3 (MCP-3), IL-2 receptor ß (IL-2Rß), IL-15 receptor {alpha} (IL-15R{alpha}), interferon receptor 2, and prostaglandin E synthase. Down-regulated genes included those encoding complement component receptor 2/CD21, platelet-activating factor acetylhydrolase, and oxidized low-density lipoprotein receptor 1 (OLR1). Pneumolysin-independent responses included down-regulation of the genes encoding CD68, CD53, CD24, transforming growth factor ß2, and signal transducers and activators of transcription 1. These results demonstrate the striking effects of pneumolysin on the host cell upon exposure to S. pneumoniae.


arrow
INTRODUCTION
 
The bacterium Streptococcus pneumoniae (pneumococcus) is a major cause of pneumonia, meningitis, bacteremia, otitis media, and sinusitis in humans. Clinical infection by this extracellular pathogen is preceded by colonization of the nasopharynx via adherence of the bacterium to the mucosal cells of the upper respiratory tract through interactions between bacterial surface adhesins and epithelial cell receptors (4, 53). Adherent bacteria are then internalized within mucosal epithelial cells via receptor-mediated endocytosis and transported across the cytoplasm, where they are released at the submucosa (54). Bacteremia may then occur by interaction with endothelial cells, allowing access to the bloodstream (49). S. pneumoniae evades phagocytosis by virtue of its capsule. Additionally, several pneumococcal proteins have been shown to influence the virulence of this organism, including pneumococcal surface protein A (PspA), pneumococcal surface adhesin A (PsaA), autolysin, neuraminidase, and pneumolysin (2, 37, 54, 56).

Pneumolysin is produced by all clinical isolates of S. pneumoniae (44, 56). It interacts with cholesterol in the cell membrane, inserting itself into the lipid bilayer and forming oligomeric pores that lead to cell lysis. Furthermore, pneumolysin activates the classical complement pathway in the absence of specific antibody by binding to the Fc region of human immunoglobulin G (8). Pneumococcal invasion of the pulmonary epithelium and endothelial cells has been shown to be pneumolysin dependent (50). Pneumolysin has numerous effects on human immune cells, including inhibition of neutrophil and monocyte function (50). In human neutrophils, pneumolysin increases intracellular calcium concentrations, phospholipase A2 activity, CD11b/CD18 expression, and superoxide production. Also, pneumolysin increases potassium efflux independently of calcium-ATPase or sodium-potassium-ATPase activity in these cells (16). Furthermore, pneumolysin causes calcium-dependent prostaglandin E2 (PGE2) and leukotriene B4 production in human neutrophils and nitric oxide, interleukin-1 (IL-1), tumor necrosis factor {alpha} (TNF-{alpha}), IL-6, and cyclooxygenase 2 production in mononuclear phagocytes (3, 15, 16, 31). In mice, chronic bacteremia rather than rapidly progressive sepsis is observed with infection by pneumolysin mutants compared to isogenic wild-type isolates (6, 7). This difference may be due to greater host resistance in mice infected with the pneumolysin-deficient isolate, suggesting that pneumolysin may impair this process.

Along with complement and antibodies, phagocytosis is a critical component of the host immune response to S. pneumoniae. Upon the organism's entry into the bloodstream, this response is likely initiated through contact with naive monocytes and macrophages, resulting in an inflammatory response and activation of complement, opsonization of bacteria, phagocytosis, and intracellular killing of the bacterium.

In an effort to further elucidate the role of pneumolysin in the host response to S. pneumoniae, we used cDNA microarray analysis to identify genes in the human monocytic cell line THP-1 that are pneumolysin responsive. Furthermore, by comparing the gene expression profiles of THP-1 cells in response to both a wild-type and pneumolysin-deficient mutant with the profile of uninfected cells, we have identified genes that are responsive to S. pneumoniae independently of pneumolysin. The pneumolysin-dependent nature of the response of select marker genes and gene products was confirmed and further characterized through semiquantitative and real-time reverse transcriptase-PCR (RT-PCR) as well as enzyme-linked immunosorbent assay (ELISA). This study characterizes the global transcriptional response of human monocytes to contact with S. pneumoniae and demonstrates the utility of cDNA microarray analysis in elucidating the role of specific virulence factors in the host-pathogen interaction.


arrow
MATERIALS AND METHODS
 
Bacterial strains and growth conditions. The pneumococcal strains used in this study included the serotype 2 strain S. pneumoniae D39 (38) and its isogenic derivative, PLN (9), which lacks pneumolysin. S. pneumoniae was grown in Todd-Hewitt broth containing 0.5% yeast extract, plated on blood agar plates (Difco Laboratories, Detroit, Mich.), and incubated at 37°C under reduced-oxygen conditions. Aliquots of exponentially growing bacteria were concentrated to 1/10 volume by centrifugation and stored at -80°C in Todd-Hewitt broth containing 0.5% yeast extract supplemented with 10% glycerol. The number of CFU per milliliter was determined by plate count on test aliquots for each strain. Aliquots were thawed and adjusted to the desired concentration prior to challenge of cell cultures.

Cell culture exposures. Human acute monocytic leukemia THP-1 cells were maintained in RPMI 1640 culture medium containing 10% fetal bovine serum, penicillin-streptomycin, L-glutamine, and 5 x 10-5 M ß-mercaptoethanol. Cells were suspended in 75-cm2 tissue culture flasks at a concentration of 106 cells per milliliter in antibiotic-free supplemented medium and coincubated with either medium alone, the virulent type 2 strain S. pneumoniae D39, or the isogenic mutant strain PLN. Coincubation was continued for 3 h for microarray and initial RT-PCR analysis and for up to 12 h for real-time PCR and ELISA analysis. Cells were incubated at 37°C in 5% CO2 at a bacterium-to-cell ratio of 100:1. Two independent experiments were carried out for the microarray hybridization analysis. For some assays, where indicated, multiple cell culture exposure experiments were performed.

RNA isolation. Total RNA was isolated by using the Trizol reagent (Invitrogen/GibcoBRL, Carlsbad, Calif.) in accordance with the manufacturer's instructions.

Probe preparation. A 10-µg sample of total RNA in diethyl pyrocarbonate-treated H2O was mixed with 2 µg of oligo(dT) primer (Invitrogen/ResGen), denatured at 70°C, and chilled on ice. This was added, in a total volume of 24 µl, to a mixture of 0.1 M dithiothreitol (Invitrogen/GibcoBRL); 20 mM (each) dATP, dGTP, and TTP (Amersham Pharmacia Biotech, Buckinghamshire, England); 300 units of Superscript II reverse transcriptase (Invitrogen/GibcoBRL); and 100 µCi [{alpha}-33P]dCTP (Amersham Pharmacia Biotech). The mixture was then incubated at 37°C for 90 min, after which 70 µl of diethyl pyrocarbonate-treated H2O was added and the mixture was placed on ice. Probes were then purified on chromatography columns and placed on ice.

Microarray hybridization and analysis. GF211 Known Genes Genefilter cDNA array (Invitrogen/ResGen) membranes, spotted with cDNA elements representing 4,133 human genes, were initially prewashed in boiling 0.5% sodium dodecyl sulfate (SDS) for 5 min with agitation. Prehybridizations were performed for 2 h at 42°C in Microhyb solution (Invitrogen/ResGen) with poly(A) (Invitrogen/ResGen) and denatured Cot-1 DNA as blocking reagents. Denatured probes were then added and incubated for 18 h at 42°C. After hybridization, the membranes were washed twice in 2x SSC (1x SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-1% SDS for 20 min (each washing) at 50°C followed by a wash in 0.5x SSC-1% SDS for 15 min at 55°C. The membranes were then exposed to phosphor screens (Molecular Dynamics, Sunnyvale, Calif.) for 2 to 5 days. Images were acquired on a Storm 860 Phosphorimager (Molecular Dynamics) and analyzed by using Pathways version 3.0 software (Invitrogen/ResGen). Normalization was performed by using the average of all data points for each array. Changes in expression levels were calculated by using normalized intensities and were given as ratios. Only elements with average signal intensities of greater than twofold that of the background in at least one experimental condition and only genes found to have a greater-than-twofold change in expression in both experiments were considered for further analysis.

RT-PCR. One microgram of total RNA from each sample was denatured in the presence of 1 µg of oligo(dT) primer at 70°C. Thereafter, the mixture was chilled on ice, and a master mix containing 50 mM Tris-HCl (pH 8.3); 75 mM KCl; 3 mM MgCl2; dATP, dCTP, dGTP, and TTP at 1.25 mM each; and 25 U of Superscript II reverse transcriptase was added to each tube. The reaction mixture was incubated for 10 min at room temperature, followed by a 60-min incubation at 37°C and a 5-min incubation at 90°C. PCR was performed by using 1 µl of the appropriate dilution of cDNA (empirically determined to yield product in the linear range for the final PCR conditions). Primer sequences used for amplification of specific genes by RT-PCR are shown in Table 1. The 18S (60°C) Classic (Ambion, Austin, Tex.) primer set was used to amplify 18S rRNA.


View this table:
[in this window]
[in a new window]
  		TABLE 1. DNA sequences and annealing temperatures of primers used in RT-PCR

Real-time RT-PCR. Real-time PCR was used to measure gene expression over time. Reverse transcription reactions using oligo(dT) were performed in accordance with the manufacturer's instructions (Advantage RT-for-PCR; BD Biosciences, San Jose, Calif.). Real-time PCR was performed on an ABI Prism 7000 sequence detection system by using TaqMan universal PCR master mix and ABI predeveloped assay reagents (Applied Biosystems, Foster City, Calif.) for macrophage inflammatory protein 1ß (MIP-1ß), IL-8, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in accordance with the manufacturer's protocols. Two independent experiments were performed. Samples were run in triplicate, and the data were pooled for each experiment. Levels of mRNAs were normalized to the levels of GAPDH mRNA.

IL-8 and MIP-1ß ELISA. IL-8 and MIP-1ß concentrations were determined with ELISA kits (R&D Systems, Minneapolis, Minn.). After exposure to experimental conditions, particulates were removed from cell cultures by centrifugation. Supernatants were stored at -70°C until assayed. All experiments and assays were performed in duplicate. Optical densities were read at the appropriate wavelength on an MRX microplate reader (Dynex Technologies, Chantilly, Va.).

Statistical analysis. Results from ELISA analysis of the three conditions tested were analyzed by using analysis of variance (ANOVA) with Tukey's correction for multiple comparisons (P = 0.001).


arrow
RESULTS
 
Microarray analysis of THP-1 cells exposed to S. pneumoniae. We used cDNA microarray analysis to characterize the transcriptional response of the human monocytic cell line THP-1, used to represent naive peripheral monocytes, to the D39 and PLN strains of S. pneumoniae. Monocyte viability, as assessed by erythrosin B exclusion, was >=90% prior to experimental use and >=80% after exposure to experimental conditions. No appreciable difference between pre- and postexperimental bacterial cell counts was observed for either isolate in either of the two independent experiments performed. Of the differentially expressed genes identified, the expression of 142 (3.4%) were found to be responsive in a pneumolysin-dependent fashion, whereas 40 (0.92%) were found to be responsive independently of pneumolysin. Genes were annotated by using cellular roles assigned by the Proteome Public HumanPSD Database (29).

Pneumolysin-dependent changes in THP-1 cell gene expression. Changes in gene expression were considered dependent on pneumolysin if there was a greater-than-twofold difference in transcription between cells exposed to D39 and those exposed to PLN and a corresponding change between either cells exposed to D39 or cells exposed to PLN and those exposed to medium alone. Of the genes evaluated, 116 were found to be up-regulated and 26 were found to be down-regulated in response to the presence of pneumolysin. These are listed in Table 2.


View this table:
[in this window]
[in a new window]
  		TABLE 2. Human monocyte genes that are pneumolysin dependent and differentially expressed in response to S. pneumoniaea

Among those up-regulated were genes for lysozyme, prostaglandin E synthase, mannose binding lectin 1, IL-1 receptor antagonist (IL-1Ra), {alpha}-catenin, cadherin 17, cell division cycle 25B, caspases 4 and 6, monocyte chemotactic protein 3 (MCP-3), IL-8, MIP-1ß, IL-2 receptor ß (IL-2Rß), IL-15 receptor {alpha} (IL-15R{alpha}), and interferon receptor 2. Those that were down-regulated included genes for complement component receptor 2/CD21 and oxidized low-density lipoprotein receptor 1 (OLR1).

Pneumolysin-independent changes in THP-1 cell gene expression. Changes in gene expression were independent of pneumolysin if there were greater-than-twofold average differences in transcription between cells exposed to PLN and those exposed to medium alone. Of the genes evaluated, one was found to be up-regulated and 38 were found to be down-regulated independently of the presence of pneumolysin. These are listed in Table 3.


View this table:
[in this window]
[in a new window]
  		TABLE 3. Human monocyte genes that are pneumolysin independent and differentially expressed in response to S. pneumoniae

The only gene observed to be up-regulated independently of pneumolysin was that for dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 4. Among those down-regulated were genes including those for CD53, CD68, CD24, transforming growth factor ß2 (TGF-ß2), and signal transducers and activators of transcription 1 (STAT1).

Analysis of mRNA by using RT-PCR. Using RT-PCR, we confirmed the differential expression of three pneumolysin-dependent genes (those for IL-8, MIP-1ß, and OLR1) in experiments with RNA obtained independently of that used in microarray hybridizations. Figure 1 shows that mRNA levels of IL-8 were increased in response to both PLN and, to a greater extent, D39, whereas mRNA levels of MIP-1ß were increased in response to D39 only. Conversely, mRNA levels of OLR1 were increased in response to PLN but decreased in response to D39, compared to those in medium alone. These data are consistent with those obtained in the microarray expression studies.



View larger version (84K):
[in this window]
[in a new window]
  		FIG. 1. RT-PCR analysis of mRNA expression of selected genes in THP-1 cells exposed for 3 h to medium alone, to PLN, or to D39. Samples were analyzed by agarose gel electrophoresis to visualize the bands. The strains or medium to which THP-1 cells were exposed are indicated across the top. Along the side is the gene for which the mRNA level was assayed. The 18S rRNA is the control gene for which expression does not change.

Further studies were undertaken to characterize the gene expression profiles of IL-8 and MIP-1ß over time by using real-time RT-PCR. Figure 2A and B show that after exposure to D39 and PLN for 3, 6, 9, and 12 h, mRNA levels of IL-8 are increased compared to levels after exposure to medium alone. Additionally, this difference is greater for cells exposed to D39 than for those exposed to PLN. In contrast, while mRNA levels of MIP-1ß are marginally increased in response to PLN at 6, 9, and 12 h postexposure, there is a marked increase in response to D39 for all time points studied. Data shown are from one representative experiment of four RT-PCR experiments in total.



View larger version (23K):
[in this window]
[in a new window]
  		FIG. 2. Shown is real-time RT-PCR analysis of mRNA expression of THP-1 cells exposed to medium alone, to PLN, or to D39 for IL-8 (A) and MIP-1ß (B). Also shown is ELISA analysis of secreted protein at the corresponding time points for IL-8 (C) and MIP-1ß (D). Data are presented as means ± standard errors of the mean. Statistical analysis was performed by using ANOVA with Tukey's correction for multiple comparisons (P <= 0.001). *, significantly different from exposure to medium alone; **, significantly different from exposure to PLN and medium alone.

Analysis of IL-8 and MIP-1ß by ELISA. To confirm that changes observed in mRNA levels corresponded with changes in protein expression, we measured IL-8 and MIP-1ß in supernatants of THP-1 cells under these experimental conditions. Figure 2C and D show that while both IL-8 and MIP-1ß are responsive to both PLN and D39, the response to PLN is less than that to D39. These differences were evident as early as 6 h for IL-8 and 3 h for MIP-1ß. These data corresponded well with mRNA levels as measured by real-time RT-PCR.

Statistical analysis. ANOVA with Tukey's correction for multiple comparisons was used to determine the significance of values among experimental groups in ELISA experiments (significance was defined as P <= 0.001).


arrow
DISCUSSION
 
Pneumolysin-dependent gene expression. We applied cDNA microarray analysis to further clarify the role of pneumolysin in the host-monocyte response to exposure to S. pneumoniae. While certain genes exhibit similar responses to both isolates, a number of genes were clearly responsive to the presence of pneumolysin. IL-1Ra was down-regulated in response to PLN but not D39. D39, but not PLN, was able to induce the expression of the genes encoding mannose-binding lectin-1 and lysozyme, while expression of the gene encoding CD21 was up-regulated by PLN but not D39.

IL-1Ra is a soluble receptor antagonist produced by a multitude of cells, including monocytes and macrophages (21). Its release is believed to attenuate the deleterious effects of IL-1. While IL-1 has been shown to be expressed in human monocytes in response to S. pneumoniae and pneumolysin, it is observed at a later time point than that studied here (15, 31). No changes in IL-1{alpha} or IL-1ß mRNA levels were observed at the 3-h time point used for cDNA array experiments. Early increases in expression of this molecule could have protective effects against a later IL-1-mediated inflammatory response or could benefit the bacterium by blunting this host response.

Mannose-binding lectin affects phagocytosis and cytokine production in phagocytes and activates complement in an antibody-independent fashion. This molecule also shows affinity for S. pneumoniae and has been shown to increase the association between Neisseria meningitides and monocytes, macrophages, and neutrophils by binding to that bacterium (33, 41). Increased production of this molecule in response to the presence of pneumolysin could serve to enhance phagocytosis but may also be a principle mediator of the inflammatory response to pneumococcus.

Lysozyme is a relatively ubiquitous antimicrobial enzyme that digests bacterial cell walls by cleaving peptidoglycan (32). It has been shown to enhance the phagocytic activity of neutrophils, stimulate monocytes, and induce autolysis in S. pneumoniae (17, 32). CD21 serves as the receptor for C3d, a degradation fragment of complement component C3, and for gp350 from Epstein-Barr virus (26). Although originally described in B-lymphocytes, CD21 has also been found to be expressed in other cell types, including monocytes. Binding of gp350 increases IL-1 and TNF-{alpha} production in human monocytes (19, 20). Since purified pneumococcal polysaccharides can activate C3 via the alternative pathway and bind to C3d in the absence of specific antibody (25), it is possible that S. pneumoniae-induced IL-1 and TNF-{alpha} production is mediated through this pathway as well. Down-regulation of CD21 would suggest an altered inflammatory response to D39 compared to that to PLN. While we observed no difference in IL-1 mRNA expression in response to D39 or PLN, others have observed differences at later time points (15). Unfortunately, the gene encoding TNF-{alpha} is not represented on the array used in the present study.

Catenins and cadherins play critical roles in regulating cytoskeletal rearrangements. Interestingly, the most up-regulated pneumolysin-dependent gene in this study, that for {alpha}-1 catenin, has been implicated in the uptake of Listeria monocytogenes in human epithelial cells (35). Furthermore, several bacterial toxins have been shown to target actin, such as the enterotoxin of Bacteroides fragilis, which is a protease specific for E-cadherin (48). Pneumolysin-dependent up-regulation of the genes encoding {alpha}-1 catenin and cadherin 17 may represent a mechanism by which this factor facilitates bacterial uptake.

A number of cell cycle control genes were found to be up-regulated in a pneumolysin-dependent fashion in this study. Relative to adherence in the G0-G1 and S phases, the adherence of S. pneumoniae to the human epithelial lung cell line A549 has been shown to increase during the G2 phase of the cell cycle due to increased cell size (11). The CDC25B phosphatase plays a critical role in the control of G2-M progression (39). It is possible that changes in expression of cell cycle control genes represent a defensive host response to S. pneumoniae to reduce bacterial adherence to host cells.

Apoptosis of macrophages has been suggested to be both a mechanism whereby bacteria can avoid immune-mediated killing and a normal host immune response. A number of bacterial species have been shown to induce macrophage apoptosis, including S. pneumoniae (22). Apoptosis of macrophages in response to opsonized serotype 1 S. pneumoniae was associated with successful phagocytosis and bacterial killing. The finding of pneumolysin-dependent up-regulation of both caspases 4 and 6 in the present study suggests that apoptosis associated with the host immune response to S. pneumoniae may be a caspase-mediated event. Up-regulation of the gene encoding cyclophilin C is consistent with this hypothesis, as this enzyme has been implicated in genome degradation during apoptosis (40).

Several genes encoding chemokines were up-regulated in response to the presence of pneumolysin, including the genes for MIP-1ß, MCP-3, and IL-8. These gene products are mediators of inflammation, chemotaxis, and cell adhesion (1, 12). In the present study, time course analysis of IL-8 and MIP-1ß gene and protein expression in THP-1 cells by real-time RT-PCR and ELISA, respectively, revealed differing responses for D39 and PLN. Without pneumolysin, the pneumococcus can elicit a moderate induction of IL-8 and MIP-1ß. However, the presence of this virulence factor is associated with a substantial increase in these chemokines.

Also up-regulated in a pneumolysin-dependent fashion was the gene encoding prostaglandin E synthase. Prostaglandin endoperoxide H2 is formed from arachidonic acid by cyclooxygenases 1 and 2, and it is subsequently converted to PGE2 by prostaglandin E synthase. Interestingly, pneumolysin-dependent up-regulation of cyclooxygenase-2 has been demonstrated in murine macrophages, but only in the presence of gamma interferon (13). Taken together, these data suggest a coordinated increase in production of PGE2 in response to the presence of pneumolysin in activated monocytes and/or macrophages.

Platelet-activating factor (PAF) acetylhydrolase is the enzyme responsible for degradation of PAF, a phospholipid which mediates intercellular interactions and inflammation (45). Decreased PAF acetylhydrolase production has been associated with the sepsis syndrome (52). The PAF receptor has been implicated as a site of attachment for virulent S. pneumoniae (18). The gene encoding the cytoplasmic {gamma}-form of PAF acetylhydrolase was up-regulated in response to PLN but not in response to D39. Of interest, the gene encoding the plasma form of this enzyme was down-regulated by both PLN and D39, although not to the extent to meet the criteria used in this study. Pneumolysin-mediated impairment of PAF acetylhydrolase expression could contribute to the host inflammatory response through increased circulating PAF. This also raises the possibility that increased PAF might compete with S. pneumoniae and thus impair it from binding to the PAF receptor.

Cathepsin E was up-regulated in a pneumolysin-dependent fashion. This enzyme is responsible for proteolytic degradation and major histocompatiblity complex class II processing for presentation of antigen on antigen-presenting cells (5). Up-regulation of this gene may enhance the presentation of pneumococcal antigens. The gene encoding serum amyloid P component (SAP) was down-regulated by PLN, but this was abolished by D39. SAP binds to DNA in chromatin to protect it from degradation and also possesses immunomodulatory properties. SAP has been shown to bind to certain bacteria, such as Streptococcus pyogenes and N. meningitidis, but not S. pneumoniae, and to elicit an antiopsonic effect, impairing phagocytosis and bacterial killing (28). SAP-/- mice have been shown to be resistant to lethal infection by organisms to which SAP binds but to be more susceptible to those which SAP does not bind, suggesting that increased SAP might be beneficial to the host during pneumococcal infection (42). Interestingly, SAP has recently been shown to be the Escherichia coli Shiga toxin 2-neutralizing factor of human plasma (34).

OLR1 was up-regulated in response to PLN but not in response to D39. OLR1 is a type II membrane glycoprotein which serves as an endocytosis receptor for oxidized low-density lipoprotein and is highly expressed in a multitude of cells, including macrophages. OLR1 has been shown to be induced by TNF-{alpha}, TGF-ß, and lipopolysaccharide. Recently OLR1 was shown to act as a cell surface receptor for Staphylococcus aureus and E. coli (51).

The genes encoding IL-2Rß and IL-15R{alpha} were both down-regulated in response to PLN but up-regulated in response to D39, while the genes encoding thioredoxin and interferon receptor 2 were both up-regulated in response to D39. Thioredoxin is a redox enzyme that exhibits chemokine-like activities, including induction of the IL-2 receptor (10). While it is interesting to speculate on the effects of pneumolysin on the response to IL-2 and IL-15 in these cells, it is important to note that no change was observed in the expression of the gamma subunit of the IL-2 receptor.

Pneumolysin-independent gene expression. Several genes were differentially expressed in a manner independent of pneumolysin. These pneumolysin-independent responsive genes included those involved in anti-pathogen response, cell-to-cell signaling, RNA polymerase II transcription, and signal transduction.

CD68 is a membrane antigen highly expressed on monocytes and macrophages that plays a role in phagocytosis of pathogens (30). It is also involved in homing of macrophages to particular sites (47) and interacts with membrane lectins and selectins in cell-cell interactions (14). CD53 is also an integral membrane protein. It is expressed on a broad range of different hematopoietic cell types, including monocytes and macrophages (43), and is involved in associating with integrins and protein kinase C to facilitate their interaction and thus their engagement in growth regulation of these cells (58). Down-regulation of CD68 and CD53 would lead to severe curtailment of the monocyte defense against pneumococcus. On the other hand, CD24 is a monocyte antigen whose expression is repressed during differentiation of monocytes (24). Its down-regulation may indicate that the monocyte has initiated the differentiation process.

TGF-ß2, a cell-signaling molecule, has many immunomodulatory roles. Previously, it has been shown to up-regulate C3 in monocytes (23). Potentially, down-regulation of this molecule would lead to less C3, the key component in both the classical and alternative complement cascades. In addition, TGF-ß2, shown to be produced by monocytes as well as other cells, has been shown to down-regulate gamma interferon and nitric oxide production in activated monocytes and macrophages (55). STAT1 is a signal transduction molecule required for gamma interferon signaling (36). MADH7, another signal transduction molecule, is a member of the Smad family of proteins. It has been shown to suppress transcription of TGF-ß responsive genes (27) and is up-regulated by TGF-ß itself (57). Therefore, down-regulation of TGF-ß in light of MADH7 down-regulation is not surprising. The ErbB2 signal transduction molecule is a tyrosine kinase receptor essential for IL-6 signaling, since down-regulation of ErbB2 has been shown to abolish activation of IL-6-responsive genes (46).

In this study, we have identified genes that are responsive to S. pneumoniae in both a pneumolysin-dependent and -independent manner. The results indicate an intricate interaction between host and pneumococcus; however, these responses demonstrate that the interaction between host and pathogen are more complex, relying on many factors in the pathogen to elicit such responses. Similar experiments with pneumococcal strains deficient in other known or putative virulence factors should be performed to determine the contribution of such factors to the pathogenesis of infection.


arrow
ACKNOWLEDGMENTS
 
This work was supported by National Institutes of Health grant AI43653 (L.S.M.), funds from the Department of Surgery (L.S.M.), and the VA Medical Research Services (E.S.).

We thank Brenda Chapman for assistance with the THP-1 cell line.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Department of Surgery, University of Mississippi Medical Center, 2500 N. State St., Jackson, MS 39216. Phone: (601) 984-6880. Fax: (601) 984-1708. E-mail: lmcdaniel{at}microbio.umsmed.edu. Back

Editor: J. N. Weiser


arrow
REFERENCES
 
    1
  1. Adams, D. H., and A. R. Lloyd. 1997. Chemokines: leucocyte recruitment and activation cytokines. Lancet 349:490-495.[CrossRef][Medline]
    2. 2
  2. Alexander, J. E., R. A. Lock, C. C. Peeters, J. T. Poolman, P. W. Andrew, T. J. Mitchell, D. Hansman, and J. C. Paton. 1994. Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect. Immun. 62:5683-5688.[Abstract/Free Full Text]
    3. 3
  3. Baba, H., I. Kawamura, C. Kohda, T. Nomura, Y. Ito, T. Kimoto, I. Watanabe, S. Ichiyama, and M. Mitsuyama. 2002. Induction of gamma interferon and nitric oxide by truncated pneumolysin that lacks pore-forming activity. Infect. Immun. 70:107-113.[Abstract/Free Full Text]
    4. 4
  4. Beachey, E. H., C. S. Giampapa, and S. N. Abraham. 1988. Bacterial adherence. Adhesin receptor-mediated attachment of pathogenic bacteria to mucosal surfaces. Am. Rev. Respir. Dis. 138:S45-S48.[Medline]
    5. 5
  5. Bennett, K., T. Levine, J. S. Ellis, R. J. Peansky, I. M. Samloff, J. Kay, and B. M. Chain. 1992. Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E. Eur. J. Immunol. 22:1519-1524.[Medline]
    6. 6
  6. Benton, K. A., M. P. Everson, and D. E. Briles. 1995. A pneumolysin-negative mutant of Streptococcus pneumoniae causes chronic bacteremia rather than acute sepsis in mice. Infect. Immun. 63:448-455.[Abstract]
    7. 7
  7. Benton, K. A., J. L. VanCott, and D. E. Briles. 1998. Role of tumor necrosis factor alpha in the host response of mice to bacteremia caused by pneumolysin-deficient Streptococcus pneumoniae. Infect. Immun. 66:839-842.[Abstract/Free Full Text]
    8. 8
  8. Berry, A. M., A. D. Ogunniyi, D. C. Miller, and J. C. Paton. 1999. Comparative virulence of Streptococcus pneumoniae strains with insertion-duplication, point, and deletion mutations in the pneumolysin gene. Infect. Immun. 67:981-985.[Abstract/Free Full Text]
    9. 9
  9. Berry, A. M., J. Yother, D. E. Briles, D. Hansman, and J. C. Paton. 1989. Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect. Immun. 57:2037-2042.[Abstract/Free Full Text]
    10. 10
  10. Bertini, R., O. M. Howard, H. F. Dong, J. J. Oppenheim, C. Bizzarri, R. Sergi, G. Caselli, S. Pagliei, B. Romines, J. A. Wilshire, M. Mengozzi, H. Nakamura, J. Yodoi, K. Pekkari, R. Gurunath, A. Holmgren, L. A. Herzenberg, and P. Ghezzi. 1999. Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells. J. Exp. Med. 189:1783-1789.[Abstract/Free Full Text]
    11. 11
  11. Berube, L. R., H. Jouishomme, and H. C. Jarrell. 1998. The nonrandom binding distribution of Streptococcus pneumoniae to type II pneumocytes in culture is dependent on the relative distribution of cells among phases and cell cycle. Can. J. Microbiol. 44:448-455.[CrossRef][Medline]
    12. 12
  12. Blanpain, C., I. Migeotte, B. Lee, J. Vakili, B. J. Doranz, C. Govaerts, G. Vassart, R. W. Doms, and M. Parmentier. 1999. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. Blood 94:1899-1905.[Abstract/Free Full Text]
    13. 13
  13. Braun, J. S., R. Novak, G. Gao, P. J. Murray, and J. L. Shenep. 1999. Pneumolysin, a protein toxin of Streptococcus pneumoniae, induces nitric oxide production from macrophages. Infect. Immun. 67:3750-3756.[Abstract/Free Full Text]
    14. 14
  14. Burgio, V. L., S. Fais, M. Boirivant, A. Perrone, and F. Pallone. 1995. Peripheral monocyte and naive T-cell recruitment and activation in Crohn's disease. Gastroenterology 109:1029-1038.[CrossRef][Medline]
    15. 15
  15. Cauwels, A., E. Wan, M. Leismann, and E. Tuomanen. 1997. Coexistence of CD 14-dependent and independent pathways for stimulation of human monocytes by gram-positive bacteria. Infect. Immun. 65:3255-3260.[Abstract]
    16. 16
  16. Cockeran, R., A. J. Theron, H. C. Steel, N. M. Matloa, T. J. Mitchell, C. Feldman, and R. Anderson. 2001. Proinflammatory interactions of pneumolysin with human neutrophils. J. Infect. Dis. 183:604-611.[CrossRef][Medline]
    17. 17
  17. Cottagnoud, P., and A. Tomasz. 1993. Triggering of pneumococcal autolysis by lysozyme. J. Infect. Dis. 167:684-690.[Medline]
    18. 18
  18. Cundell, D. R., N. P. Gerard, C. Gerard, I. Idanpaan-Heikkila, and E. I. Tuomanen. 1995. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 377:435-438.[CrossRef][Medline]
    19. 19
  19. D'Addario, M., A. Ahmad, A. Morgan, and J. Menezes. 2000. Binding of the Epstein-Barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF-alpha gene expression in monocytic cells via NF-kappaB involving PKC, P13-K and tyrosine kinases. J. Mol. Biol. 298:765-778.[CrossRef][Medline]
    20. 20
  20. D'Addario, M., A. Ahmad, J. W. Xu, and J. Menezes. 1999. Epstein-Barr virus envelope glycoprotein gp350 induces NF-kappaB activation and IL-1beta synthesis in human monocytes-macrophages involving PKC and P13-K. FASEB J. 13:2203-2213.[Abstract/Free Full Text]
    21. 21
  21. Dinarello, C. A. 1996. Biologic basis for interleukin-1 disease. Blood 87:2095-2147.[Abstract/Free Full Text]
    22. 22
  22. Dockrell, D. H., M. Lee, D. H. Lynch, and R. C. Read. 2001. Immune-mediated phagocytosis and killing of Streptococcus pneumoniae are associated with direct and bystander macrophage apoptosis. J. Infect. Dis. 184:713-722.[CrossRef][Medline]
    23. 23
  23. Drouin, S. M., S. C. Kiley, J. A. Carlino, and S. R. Barnum. 1998. Transforming growth factor-beta2 regulates C3 secretion in monocytes through a protein kinase C-dependent pathway. Mol. Immunol. 35:1-11.[CrossRef][Medline]
    24. 24
  24. Graeber, T. G., and K. Shuai. 2000. Rapid gene repression triggered by interleukin-6 at the onset of monocyte differentiation. Biochem. Biophys. Res. Commun. 267:863-869.[CrossRef][Medline]
    25. 25
  25. Griffioen, A. W., G. T. Rijkers, P. Janssens-Korpela, and B. J. Zegers. 1991. Pneumococcal polysaccharides complexed with C3d bind to human B lymphocytes via complement receptor type 2. Infect. Immun. 59:1839-1845.[Abstract/Free Full Text]
    26. 26
  26. Griffioen, A. W., E. A. Toebes, B. J. Zegers, and G. T. Rijkers. 1992. Role of CR2 in the human adult and neonatal in vitro antibody response to type 4 pneumococcal polysaccharide. Cell. Immunol. 143:11-22.[CrossRef][Medline]
    27. 27
  27. Hanyu, A., Y. Ishidou, T. Ebisawa, T. Shimanuki, T. Imamura, and K. Miyazono. 2001. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling. J. Cell Biol. 155:1017-1027.[Abstract/Free Full Text]
    28. 28
  28. Hind, C. R., P. M. Collins, M. L. Baltz, and M. B. Pepys. 1985. Human serum amyloid P component, a circulating lectin with specificity for the cyclic 4,6-pyruvate acetal of galactose. Interactions with various bacteria. Biochem. J. 225:107-111.[Medline]
    29. 29
  29. Hodges, P. E., P. M. Carrico, J. D. Hogan, K. E. O'Neill, J. J. Owen, M. Mangan, B. P. Davis, J. E. Brooks, and J. L. Garrels. 2002. Annotating the human proteome: the Human Proteome Survey Database (HumanPSD) and in-depth target database for G protein-coupled receptors (GPCR-PD) from Incyte Genomics. Nucleic Acids Res. 30:137-141.[Abstract/Free Full Text]
    30. 30
  30. Holness, C. L., and D. L. Simmons. 1993. Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 81:1607-1613.[Abstract/Free Full Text]
    31. 31
  31. Houldsworth, S., P. W. Andrew, and T. J. Mitchell. 1994. Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1ß by human mononuclear phagocytes. Infect. Immun. 62:1501-1503.[Abstract/Free Full Text]
    32. 32
  32. Ibrahim, H. R., U. Thomas, and A. Pellegrini. 2001. A helix-loop-helix peptide at the upper lip of the active site cleft of lysozyme confers potent antimicrobial activity with membrane permeabilization action. J. Biol. Chem. 276:43767-43774.[Abstract/Free Full Text]
    33. 33
  33. Jack, D. L., R. C. Read, A. J. Tenner, M. Frosch, M. W. Turner, and N. J. Klein. 2001. Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J. Infect. Dis. 184:1152-1162.[CrossRef][Medline]
    34. 34
  34. Kimura, T., S. Tani, Y. Matsumoto, and T. Takeda. 2001. Serum amyloid P component is the Shiga toxin 2-neutralizing factor in human blood. J. Biol. Chem. 276:41576-41579.[Abstract/Free Full Text]
    35. 35
  35. Lecuit, M., R. Hurme, J. Pizarro-Cerda, H. Ohayon, B. Geiger, and P. Cossart. 2000. A role for alpha-and beta-catenins in bacterial uptake. Proc. Natl. Acad. Sci. USA 97:10008-10013.[Abstract/Free Full Text]
    36. 36
  36. Lehtonen, A., S. Matikainen, and I. Julkunen. 1997. Interferons up-regulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages. J. Immunol. 159:794-803.[Abstract]
    37. 37
  37. McDaniel, L. S., D. O. McDaniel, S. K. Hollingshead, and D. E. Briles. 1998. Comparison of the PspA sequence from Streptococcus pneumoniae EF5668 to the previously identified PspA sequence from strain Rx1 and ability of PspA from EF5668 to elicit protection against pneumococci of different capsular types. Infect. Immun. 66:4748-4754.[Abstract/Free Full Text]
    38. 38
  38. McDaniel, L. S., G. Scott, J. F. Kearney, and D. E. Briles. 1984. Monoclonal antibodies against protease sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae. J. Exp. Med. 160:386-397.[Abstract/Free Full Text]
    39. 39
  39. Miyata, H., Y. Doki, H. Yamamoto, K. Kishi, H. Takemoto, Y. Fujiwara, T. Yasuda, M. Yano, M. Inoue, H. Shiozaki, I. B. Weinstein, and M. Monden. 2001. Overexpression of CDC25B overrides radiation-induced G2-M arrest and results in increased apoptosis in esophageal cancer cells. Cancer Res. 61:3188-3193.[Abstract/Free Full Text]
    40. 40
  40. Montague, J. W., F. M. Hughes, Jr., and J. A. Cidlowski. 1997. Native recombinant cyclophilins A, B, and C degrade DNA independently of peptidylproplyl cis-trans-isomerase activity. Potential roles of cyclophilins in apoptosis. J. Biol. Chem. 272:6677-6684.[Abstract/Free Full Text]
    41. 41
  41. Neth, O., D. L. Jack, A. W. Dodds, H. Holzel, N. J. Klein, and M. W. Turner. 2000. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect. Immun. 68:688-693.[Abstract/Free Full Text]
    42. 42
  42. Noursadeghi, M., M. C. Bickerstaff, J. R. Gallimore, J. Herbert, J. Cohen, and M. B. Pepys. 2000. Role of serum amyloid P component in bacterial infection: protection of the host or protection of the pathogen. Proc. Natl. Acad. Sci. USA 97:1484-1489.
    43. 43
  43. Olweus, J., F. Lund-Johansen, and V. Horejsi. 1993. CD53, a protein with four membrane-spanning domains, mediates signal transduction in human monocytes and B cells. J. Immunol. 151:707-716.[Abstract]
    44. 44
  44. Paton, J. C., P. W. Andrew, G. J. Boulnois, and T. J. Mitchell. 1993. Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins. Annu. Rev. Microbiol. 47:89-115.[Medline]
    45. 45
  45. Prescott, S. M., G. A. Zimmerman, D. M. Stafforini, and T. M. McIntyre. 2000. Platelet-activating factor and related lipid mediators. Annu. Rev. Biochem. 69:419-445.[CrossRef][Medline]
    46. 46
  46. Qiu, Y., L. Ravi, and H. J. Kung. 1998. Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells. Nature 393:83-85.[CrossRef][Medline]
    47. 47
  47. Regezi, J. A., L. A. Macphail, D. W. Richards, and J. S. Greenspan. 1993. A study of macrophages, macrophage-related cells, and endothelial adhesion molecules in recurrent aphthous ulcers in HIV-positive patients. J. Dent. Res. 72:1549-1553.[Abstract/Free Full Text]
    48. 48
  48. Richard, J. F., L. Petit, M. Gibert, J. C. Marvaud, C. Bouchaud, and M. R. Popoff. 1999. Bacterial toxins modifying the actin cytoskeleton. Int. Microbiol. 2:185-194.[Medline]
    49. 49
  49. Ring, A., J. N. Weiser, and E. I. Tuomanen. 1998. Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. J. Clin. Investig. 102:347-360.[Medline]
    50. 50
  50. Rubins, J. B., and E. N. Janoff. 1998. Pneumolysin: a multifunctional pneumococcal virulence factor. J. Lab. Clin. Med. 131:21-27.[CrossRef][Medline]
    51. 51
  51. Shimaoka, T., N. Kume, M. Minami, K. Hayshida, T. Sawamura, T. Kita, and S. Yonehara. 2001. LOX-1 supports adhesion of Gram-positive and Gram-negative bacteria. J. Immunol. 166:5108-5114.[Abstract/Free Full Text]
    52. 52
  52. Trimoreau, F., B. Francois, A. Desachy, A. Besse, P. Vignon, and Y. Denizot. 2000. Platelet-activating factor acetylhydrolase and haemophagocytosis in the sepsis syndrome. Mediators Inflamm. 9:197-200.[CrossRef][Medline]
    53. 53
  53. Tuomanen, E. I. 1997. The biology of pneumococcal infection. Pediatr. Res. 42:253-258.[Medline]
    54. 54
  54. Tuomanen, E. I., R. Austrian, and H. R. Masure. 1995. Pathogenesis of pneumococcal infection. N. Engl. J. Med. 332:1280-1284.[Free Full Text]
    55. 55
  55. Vodovotz, Y., C. Bogdan, J. Paik, Q. W. Xie, and C. Nathan. 1993. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J. Exp. Med. 178:605-613.[Abstract/Free Full Text]
    56. 56
  56. Wizemann, T. M., J. E. Adamou, and S. Langermann. 1999. Adhesins as targets for vaccine development. Emerg. Infect. Dis. 5:395-403.[Medline]
    57. 57
  57. Wu, D., S. Luo, Y. Wang, L. Zhuang, Y. Chen, and C. Peng. 2001. Smads in human trophoblast cells: expression, regulation and role in TGF-beta-induced transcriptional activity. Mol. Cell. Endocrinol. 175:111-121.[CrossRef][Medline]
    58. 58
  58. Zhang, X. A., A. L. Bontrager, and M. E. Hemler. 2001. Transmembrane-4 superfamily proteins associate with activated protein kinase C (PKC) and link PKC to specific beta(1) integrins. J. Biol. Chem. 276:25005-25013.[Abstract/Free Full Text]

Infection and Immunity, April 2003, p. 2087-2094, Vol. 71, No. 4
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.4.2087-2094.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Bootsma, H. J., Egmont-Petersen, M., Hermans, P. W. M. (2007). Analysis of the In Vitro Transcriptional Response of Human Pharyngeal Epithelial Cells to Adherent Streptococcus pneumoniae: Evidence for a Distinct Response to Encapsulated Strains. Infect. Immun. 75: 5489-5499 [Abstract] [Full Text]  
  • Marquart, M. E., Monds, K. S., McCormick, C. C., Dixon, S. N., Sanders, M. E., Reed, J. M., McDaniel, L. S., Caballero, A. R., O'Callaghan, R. J. (2007). Cholesterol as Treatment for Pneumococcal Keratitis: Cholesterol-Specific Inhibition of Pneumolysin in the Cornea. IOVS 48: 2661-2666 [Abstract] [Full Text]  
  • Quin, L. R., Moore, Q. C. III, McDaniel, L. S. (2007). Pneumolysin, PspA, and PspC Contribute to Pneumococcal Evasion of Early Innate Immune Responses during Bacteremia in Mice. Infect. Immun. 75: 2067-2070 [Abstract] [Full Text]  
  • Paterson, G. K., Mitchell, T. J. (2006). Innate immunity and the pneumococcus. Microbiology 152: 285-293 [Abstract] [Full Text]  
  • Thornton, J., McDaniel, L. S. (2005). THP-1 Monocytes Up-Regulate Intercellular Adhesion Molecule 1 in Response to Pneumolysin from Streptococcus pneumoniae. Infect. Immun. 73: 6493-6498 [Abstract] [Full Text]  
  • Cockeran, R., Theron, A. J., Feldman, C., Mitchell, T. J., Anderson, R. (2004). Docosahexaenoic Acid and Eicosapentaenoic Acid Antagonize the Proinflammatory Interactions of Pneumolysin with Human Neutrophils. Infect. Immun. 72: 4327-4329 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rogers, P. D.
Right arrow Articles by McDaniel, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rogers, P. D.
Right arrow Articles by McDaniel, L. S.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»